Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma.

MLA

Tijeras-Raballand, Annemilaï, et al. “Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma.” Gastroenterology Research & Practice, vol. 2010, Jan. 2010, pp. 1–15. EBSCOhost, https://doi.org/10.1155/2010/640797.

APA

Tijeras-Raballand, A., Hainaud-Hakim, P., Contreres, J.-O., Gest, C., Le Henaff, C., Levy, B. I., Pocard, M., Soria, C., & Dupuy, E. (2010). Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma. Gastroenterology Research & Practice, 2010, 1–15. https://doi.org/10.1155/2010/640797

Chicago

Tijeras-Raballand, Annemilaï, Patricia Hainaud-Hakim, Jean-Olivier Contreres, Caroline Gest, Carole Le Henaff, Bernard I. Levy, Marc Pocard, Claudine Soria, and Evelyne Dupuy. 2010. “Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma.” Gastroenterology Research & Practice 2010 (January): 1–15. doi:10.1155/2010/640797.